The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL

1. Rejeski, K.
2. Wang, Y.
3. Albanyan, O.
4. Munoz, J.
5. Sesques, P.
6. Iacoboni, G.
7. Lopez-Corral, L.
8. Ries, I.
9. Bücklein, V.L.
10. Mohty, R.
11. Dreyling, M.
12. Baluch, A.
13. Shah, B.
14. Locke, F.L.
15. Hess, G.
16. Barba, P.
17. Bachy, E.
18. Lin, Y.
19. Subklewe, M.
20. Jain, M.D.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1002/AJH.27056 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus